ArticleVeterinary medicine and science2025
Do Intravenous Butaphosphan and Cyanocobalamin Combination Affect Insulin Resistance and Metabolic Profile of Dairy Goats During Their Transition Period?
Article in Veterinary medicine and science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundInsulin resistance during early lactation in goats has been a topic of interest for researchers, as addressing this issue can significantly improve their metabolic health.
objectivesTo investigate the potential of butaphosphan and cyanocobalamin in controlling insulin resistance, we conducted a study with the hypothesis that this combination may mitigate insulin resistance in dairy goats.
methodsTen adult goats were divided equally into two groups: Ctrl and B+C. The Ctrl group received 6 mL of normal saline, while the second group was administered 6 mL of 10% butaphosphan and 0.005% cyanocobalamin on days 21, 20, 19, and 12, 11, 10, and 3, 2, 1 before parturition. On the 10th and 20th days after parturition, blood samples were gathered to analyze the levels of different metabolites and evaluate insulin resistance/sensitivity through an intravenous glucose tolerance test and surrogate indices. Body condition scores, milk production, and weight gain of the kids were also recorded during the study.
resultsAlthough the B+C group showed slightly higher insulin responsiveness than the Ctrl group in the intravenous glucose tolerance test, but the difference was insignificant. Comparably, no significant differences were noticed in the remaining metabolic indicators amidst the Ctrl and B+C groups.
conclusionsThe lack of substantial differences can be attributed to the limited sample size and the prescribed drug dosage. Further investigations with higher doses exceeding 6 mL are warranted to explore potential effects. Additionally, species-specific differences in ruminants might exist, and caprine metabolism of the compound might differ from that of bovine and ovine. Consequently, we recommend conducting more studies in this field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.